Total Visits
| Views | |
|---|---|
| Obinutuzumab ... | 53 |
Total Visits Per Month
| November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|
| Obinutuzumab ... | 1 | 1 | 2 | 1 | 1 | 0 | 0 |
File Visits
| Views | |
|---|---|
| obinutuzumab_plus_fludarabine_cyclophosphamide_previously_untreated_fit_patients_chronic_lymphocytic_leukemia_subgroup_analysis_green_study_2020.pdf | 30 |
| obinutuzumab_plus_fludarabine_cyclophosphamide_previously_untreated_fit_patients_chronic_lymphocytic_leukemia_subgroup_analysis_green_study_2020_figura1.tif | 15 |
| obinutuzumab_plus_fludarabine_cyclophosphamide_previously_untreated_fit_patients_chronic_lymphocytic_leukemia_subgroup_analysis_2020_material_suplementari.pdf | 12 |
Top country views
| Views | |
|---|---|
| United States | 27 |
| Spain | 5 |
| Sweden | 5 |
| China | 3 |
| Germany | 3 |
| Finland | 2 |
| Ireland | 2 |
| Singapore | 2 |
| Slovenia | 2 |
| Belgium | 1 |
Top cities views
| Views | |
|---|---|
| Chandler | 10 |
| Barcelona | 5 |
| Ashburn | 4 |
| Dublin | 2 |
| Helsinki | 2 |
| Koper | 2 |
| Shanghai | 2 |
| Boardman | 1 |
| Brooklyn | 1 |
| Brussels | 1 |